Paper41526546
The contribution of the membrane-bound complement regulatory proteins CD46 and CD55 in phases of acute lymphocytic leukemia and acute myelogenous leukemia.
Onsi LA and 5 others. Sci Rep, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. The contribution of the membrane-bound complement regulatory proteins CD46 and CD55 in phases of acute lymphocytic leukemia and acute myelogenous leukemia. Papers, record 41526546. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41526546
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The contribution of the membrane-bound complement regulatory proteins CD46 and CD55 in phases of acute lymphocytic leukemia and acute myelogenous leukemia.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Membrane Cofactor Protein | Major topic |
| CD55 Antigens | Major topic |
| Leukemia, Myeloid, Acute | Major topic |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | Major topic |
| Humans | |
| Female | |
| Cell Line, Tumor | |
| Male | |
| Middle Aged | |
| Adult | |
| Gene Expression Regulation, Leukemic |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31379815 | The Complement Receptors C3aR and C5aR Are a New Class of Immune Checkpoint Receptor in Cancer Immunotherapy. | Front Immunol | 2019 | https://conductscience.org/library/papers/31379815 | PubMed |
| 2 | 18542048 | Expression of galectin-3 in the tumor immune response in colon cancer. | Lab Invest | 2008 | https://conductscience.org/library/papers/18542048 | PubMed |
| 3 | 2665442 | The regulators of complement activation (RCA) gene cluster. | Adv Immunol | 1989 | https://conductscience.org/library/papers/2665442 | PubMed |
| 4 | 19025121 | The role of membrane complement regulatory proteins in cancer immunotherapy. | Adv Exp Med Biol | 2008 | https://conductscience.org/library/papers/19025121 | PubMed |
| 5 | 2474570 | Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells. | J Clin Invest | 1989 | https://conductscience.org/library/papers/2474570 | PubMed |
| 6 | 16923853 | Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. | J Exp Med | 2006 | https://conductscience.org/library/papers/16923853 | PubMed |
| 7 | 1384649 | Levels of complement regulatory proteins, CD35 (CR1), CD46 (MCP) and CD55 (DAF) in human haematological malignancies. | Br J Haematol | 1992 | https://conductscience.org/library/papers/1384649 | PubMed |
| 8 | 11846609 | Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. | Methods | 2001 | https://conductscience.org/library/papers/11846609 | PubMed |
| 9 | 20694009 | Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells. | Nat Immunol | 2010 | https://conductscience.org/library/papers/20694009 | PubMed |
| 10 | 7511675 | Structure and function of decay accelerating factor CD55. | J Lab Clin Med | 1994 | https://conductscience.org/library/papers/7511675 | PubMed |
| 11 | 12615893 | Does the immune system see tumors as foreign or self? | Annu Rev Immunol | 2003 | https://conductscience.org/library/papers/12615893 | PubMed |
| 12 | 896122 | Serum complement levels in patients with digestive tract carcinomas and other neoplastic diseases. | Oncology | 1977 | https://conductscience.org/library/papers/896122 | PubMed |
| 13 | 30300579 | Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy. | Cancer Cell | 2018 | https://conductscience.org/library/papers/30300579 | PubMed |
| 14 | 10934224 | A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. | J Exp Med | 2000 | https://conductscience.org/library/papers/10934224 | PubMed |
| 15 | 38385704 | Sex- and species-associated differences in complement-mediated immunity in humans and rhesus macaques. | mBio | 2024 | https://conductscience.org/library/papers/38385704 | PubMed |
| 16 | 23940286 | Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer. | J Natl Cancer Inst | 2013 | https://conductscience.org/library/papers/23940286 | PubMed |
| 17 | 24272362 | The role of complement in tumor growth. | Adv Exp Med Biol | 2014 | https://conductscience.org/library/papers/24272362 | PubMed |
| 18 | 6462464 | Cellular immunity and complement levels in hosts with brain tumours. | Neurosurg Rev | 1984 | https://conductscience.org/library/papers/6462464 | PubMed |
| 19 | 20870736 | Cancer and the complement cascade. | Mol Cancer Res | 2010 | https://conductscience.org/library/papers/20870736 | PubMed |
| 20 | 7514955 | Protection of thyroid cancer cells by complement-regulatory factors. | Cancer | 1994 | https://conductscience.org/library/papers/7514955 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD46 | 4179 | PubTator's text mining | https://conductscience.org/library/genes/4179 | NCBI Gene |
| CD55 | 1604 | PubTator's text mining | https://conductscience.org/library/genes/1604 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41526546
GET https://conductscience.org/api/papers/v1/41526546/references?page=2